Log In
Print
BCIQ
Print
Print this Print this
 

CT327 (formerly CT 301/P)

  Manage Alerts
Collapse Summary General Information
Company Creabilis S.A.
DescriptionTopical neurotrophic tyrosine kinase receptor 1 (NTRK1; TrkA) inhibitor
Molecular Target Neurotrophic tyrosine kinase receptor 1 (NTRK1) (TrkA)
Mechanism of Action 
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today